Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Parameswaran Hari

Showing results (31-40 of 255) with videos related to

Pageof 26
Sort By:
British Journal of Haematology|February 1, 2011
CD200 expression in plasma cell myelomaHoratiu Olteanu, Alexandra M Harrington, Parameswaran Hari, et al.
Future Oncology (London, England)|October 19, 2019
Lenalidomide maintenance post-transplantation in newly diagnosed multiple myeloma: real-world outcomes and costsParameswaran Hari, Brian Ung, Safiya Abouzaid, et al.
Case Reports in Hematology|April 22, 2021
Pulmonary Lymphangitic Spread of Multiple Myeloma as Early Relapse after Autologous Stem Cell TransplantationBicky Thapa, Gulrayz Ahmed, Meera Mohan, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|June 2, 2016
Moving Beyond Autologous Transplantation in Multiple Myeloma: Consolidation, Maintenance, Allogeneic Transplant, and Immune TherapyAmrita Krishnan, Ravi Vij, Jesse Keller, et al.
Medicine|June 28, 2024
Clinical and economic burden of medicare beneficiaries with multiple myeloma and renal impairment: An observational studyParameswaran Hari, Dominick Latremouille-Viau, Peggy Lin, et al.
The American Journal of Gastroenterology|November 15, 2006
Suppressive anti-HCV therapy for prevention of donor to recipient transmission in stem cell transplantationSri Naveen Surapaneni, Parameswaran Hari, Josh Knox, et al.
JCO Oncology Practice|July 1, 2020
Treatment-Emergent Tumor Lysis Syndrome With PI3Kδ-γ Inhibition After CAR T-Cell Therapy for Chronic Lymphocytic LeukemiaNirav N Shah, James H Jerkins, Bryon D Johnson, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|July 26, 2019
Baseline patient-reported outcomes in light-chain amyloidosis patients enrolled on an interventional clinical trialAnita D'Souza, Parameswaran Hari, Marcelo Pasquini, et al.
Cytotherapy|September 20, 2021
Manufacturing chimeric antigen receptor T cells from cryopreserved peripheral blood cells: time for a collect-and-freeze model?Katie Palen, Joanna Zurko, Bryon D Johnson, et al.
Leukemia Research|July 27, 2018
Incidence and survival of therapy related myeloid neoplasm in United StatesGuru Subramanian Guru Murthy, Mehdi Hamadani, Binod Dhakal, et al.
Pageof 26

Showing results (31-40 of 255) with videos related to

Sort By:
Pageof 26
British Journal of Haematology|February 1, 2011
CD200 expression in plasma cell myelomaHoratiu Olteanu, Alexandra M Harrington, Parameswaran Hari, et al.
Future Oncology (London, England)|October 19, 2019
Lenalidomide maintenance post-transplantation in newly diagnosed multiple myeloma: real-world outcomes and costsParameswaran Hari, Brian Ung, Safiya Abouzaid, et al.
Case Reports in Hematology|April 22, 2021
Pulmonary Lymphangitic Spread of Multiple Myeloma as Early Relapse after Autologous Stem Cell TransplantationBicky Thapa, Gulrayz Ahmed, Meera Mohan, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|June 2, 2016
Moving Beyond Autologous Transplantation in Multiple Myeloma: Consolidation, Maintenance, Allogeneic Transplant, and Immune TherapyAmrita Krishnan, Ravi Vij, Jesse Keller, et al.
Medicine|June 28, 2024
Clinical and economic burden of medicare beneficiaries with multiple myeloma and renal impairment: An observational studyParameswaran Hari, Dominick Latremouille-Viau, Peggy Lin, et al.
The American Journal of Gastroenterology|November 15, 2006
Suppressive anti-HCV therapy for prevention of donor to recipient transmission in stem cell transplantationSri Naveen Surapaneni, Parameswaran Hari, Josh Knox, et al.
JCO Oncology Practice|July 1, 2020
Treatment-Emergent Tumor Lysis Syndrome With PI3Kδ-γ Inhibition After CAR T-Cell Therapy for Chronic Lymphocytic LeukemiaNirav N Shah, James H Jerkins, Bryon D Johnson, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|July 26, 2019
Baseline patient-reported outcomes in light-chain amyloidosis patients enrolled on an interventional clinical trialAnita D'Souza, Parameswaran Hari, Marcelo Pasquini, et al.
Cytotherapy|September 20, 2021
Manufacturing chimeric antigen receptor T cells from cryopreserved peripheral blood cells: time for a collect-and-freeze model?Katie Palen, Joanna Zurko, Bryon D Johnson, et al.
Leukemia Research|July 27, 2018
Incidence and survival of therapy related myeloid neoplasm in United StatesGuru Subramanian Guru Murthy, Mehdi Hamadani, Binod Dhakal, et al.
Pageof 26